Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05KOA
|
|||
| Former ID |
DIB007267
|
|||
| Drug Name |
Prophylactic DNA vaccine
|
|||
| Synonyms |
Prophylactic DNA vaccine (HBV); HBV DNA vaccine (prophylactic), Powderject; HBV prophylactic DNA vaccine, PowderJect/Glaxo Wellcome; Prophylactic DNA vaccine (HBV), Powderject; Prophylactic DNA vaccine (HBV), PowderJect/GlaxoSmithKline
Click to Show/Hide
|
|||
| Indication | Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Terminated | [1] | |
| Company |
PowderJect Pharmaceuticals plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B. Dev Biol (Basel). 2000;104:115-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.